
Jagdish Patel
Examiner (ID: 9244, Phone: (571)272-6748 , Office: P/3696 )
| Most Active Art Unit | 3693 |
| Art Unit(s) | 2765, 3693, 3624, 2164, 2762, 3696 |
| Total Applications | 786 |
| Issued Applications | 531 |
| Pending Applications | 86 |
| Abandoned Applications | 169 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17170748
[patent_doc_number] => 20210324418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => RECOMBINANT VIRAL VECTORS AND NUCLEIC ACIDS FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/326884
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326884 | RECOMBINANT VIRAL VECTORS AND NUCLEIC ACIDS FOR PRODUCING THE SAME | May 20, 2021 | Pending |
Array
(
[id] => 18737941
[patent_doc_number] => 20230346843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Stem Cells for Treatment of Respiratory Disorders
[patent_app_type] => utility
[patent_app_number] => 17/923124
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923124 | Stem Cells for Treatment of Respiratory Disorders | May 6, 2021 | Pending |
Array
(
[id] => 17185503
[patent_doc_number] => 20210332388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/237747
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237747 | COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS | Apr 21, 2021 | Abandoned |
Array
(
[id] => 18497394
[patent_doc_number] => 20230220024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Compositions for Treatment of Vascular Disease
[patent_app_type] => utility
[patent_app_number] => 17/996753
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -90
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996753 | Compositions for Treatment of Vascular Disease | Apr 20, 2021 | Pending |
Array
(
[id] => 17141950
[patent_doc_number] => 20210309962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => COMPOSITIONS AND METHODS UTILIZING AMNIOTIC FLUID STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/219371
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219371 | COMPOSITIONS AND METHODS UTILIZING AMNIOTIC FLUID STEM CELLS | Mar 30, 2021 | Abandoned |
Array
(
[id] => 18350298
[patent_doc_number] => 20230138409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FACTOR IX THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/913477
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913477 | NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FACTOR IX THERAPEUTICS | Mar 23, 2021 | Pending |
Array
(
[id] => 16946756
[patent_doc_number] => 20210205447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => CYTOTOXIC IMMUNOSTIMULATING PARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/209926
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209926 | Cytotoxic immunostimulating particles and uses thereof | Mar 22, 2021 | Issued |
Array
(
[id] => 18362302
[patent_doc_number] => 20230143893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => ISOLATION AND PURIFICATION OF EXOSOMES FOR REGENERATIVE MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/913301
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913301 | ISOLATION AND PURIFICATION OF EXOSOMES FOR REGENERATIVE MEDICINE | Mar 22, 2021 | Abandoned |
Array
(
[id] => 18244644
[patent_doc_number] => 20230076955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => DNA Amplification Method
[patent_app_type] => utility
[patent_app_number] => 17/796334
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796334 | DNA Amplification Method | Feb 2, 2021 | Pending |
Array
(
[id] => 18178264
[patent_doc_number] => 20230038993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/165821
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165821 | COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE | Feb 1, 2021 | Abandoned |
Array
(
[id] => 17274805
[patent_doc_number] => 20210381003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/144933
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144933 | GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE | Jan 7, 2021 | Abandoned |
Array
(
[id] => 18162770
[patent_doc_number] => 20230029363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PRODUCTION OF RECOMBINANT PROTEINS USING FAH AS THE SELECTION MARKER
[patent_app_type] => utility
[patent_app_number] => 17/757131
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757131 | PRODUCTION OF RECOMBINANT PROTEINS USING FAH AS THE SELECTION MARKER | Dec 13, 2020 | Abandoned |
Array
(
[id] => 18003539
[patent_doc_number] => 20220362305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHOD FOR COATING AND DRYING HETEROGENOUS STEM CELL DERIVED EXTRA-CELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/755609
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755609 | METHOD FOR COATING AND DRYING HETEROGENOUS STEM CELL DERIVED EXTRA-CELLULAR VESICLES | Nov 1, 2020 | Abandoned |
Array
(
[id] => 18784011
[patent_doc_number] => 20230371483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => METHODS AND COMPOSITIONS FOR SEXING AND STERILIZATION IN DROSOPHILA SUZUKII AND AEDES AEGYPTI
[patent_app_type] => utility
[patent_app_number] => 17/629348
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629348
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629348 | METHODS AND COMPOSITIONS FOR SEXING AND STERILIZATION IN DROSOPHILA SUZUKII AND AEDES AEGYPTI | Jul 23, 2020 | Pending |
Array
(
[id] => 17830473
[patent_doc_number] => 20220267777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF RPE65
[patent_app_type] => utility
[patent_app_number] => 17/625290
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625290 | DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF RPE65 | Jul 9, 2020 | Pending |
Array
(
[id] => 18005293
[patent_doc_number] => 20220364059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => PRIMING MEDIA AND METHODS FOR STEM CELL CULTURE AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/624347
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624347 | PRIMING MEDIA AND METHODS FOR STEM CELL CULTURE AND THERAPY | Jul 5, 2020 | Pending |
Array
(
[id] => 18418536
[patent_doc_number] => 20230172994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => METHODS OF PROMOTING VASCULOGENESIS
[patent_app_type] => utility
[patent_app_number] => 17/620650
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620650 | METHODS OF PROMOTING VASCULOGENESIS | Jun 18, 2020 | Pending |
Array
(
[id] => 17761714
[patent_doc_number] => 20220235326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => ENHANCEMENT OF FIBROBLAST THERAPEUTIC ACTIVITY BY RNA
[patent_app_type] => utility
[patent_app_number] => 17/596336
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596336 | ENHANCEMENT OF FIBROBLAST THERAPEUTIC ACTIVITY BY RNA | Jun 11, 2020 | Abandoned |
Array
(
[id] => 17735986
[patent_doc_number] => 20220221445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => USES OF PATIENT-DERIVED INTESTINAL ORGANOIDS FOR CELIAC DISEASE DIAGNOSIS SCREENING AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/613430
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613430 | USES OF PATIENT-DERIVED INTESTINAL ORGANOIDS FOR CELIAC DISEASE DIAGNOSIS SCREENING AND TREATMENT | Jun 2, 2020 | Pending |
Array
(
[id] => 17748188
[patent_doc_number] => 20220226391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS AND METHODS FOR THYMIC REGENERATION AND T-CELL RECONSTITUTION
[patent_app_type] => utility
[patent_app_number] => 17/614521
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614521 | COMPOSITIONS AND METHODS FOR THYMIC REGENERATION AND T-CELL RECONSTITUTION | May 27, 2020 | Pending |